Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
newman, PWO was gone on feb 28. The PR from amarin used the word immediate departure. I think one sentence in the Conf call the next day was devoted to KM saying gonzo see ya!
Then in another PR it was mentioned that a new COB will be announced shortly.
Does anyone want to take a guess who the new COB will be?
Hopefully, AD.
KM lied about the status of China and how he's on top of the current status. Check one of my posts about cc transcript re china status. Without Eddings IPO they can not pay the upfront fees to market V in China exception being one island of Taiwan. Edding doesn't have the cash period!
Eddingpharm Valuation & Funding
Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 03-Feb-2023 Cancelled Generating Revenue
6. Later Stage VC (Series E) 29-Jul-2019
Completed Generating Revenue
5. Later Stage VC (Series D1) 18-Jan-2019
Completed Generating Revenue
4. Later Stage VC (Series D) 08-Nov-2016
Completed Generating Revenue
3. Later Stage VC (Series C) 29-Feb-2016
Completed Generating Revenue
2. Later Stage VC (Series B) 05-Aug-2010 $24M $36M Completed Generating Revenue
1. Later Stage VC (Series A) 29-May-2008 $12M $12M Completed Generating Revenue
meowzo, implosion all of the above.
meowzo, validated they'll be gone shortly. Pun intended
AMAZING
http://archive.fast-edgar.com/20230302/AT22S22CZZ2RI2ZZ27JJ2WYRA44NEZ22Z252
Filed on: March 2, 2023
Meow, did u see SI? Just sayin
Capt.
https://hlstherapeutics.investorroom.com/2023-03-02-HLS-Therapeutics-to-Host-Q4-and-Fiscal-2022-Financial-Results-Conference-Call
Is anyone interested HLS and PFE.
BBI, in the financials there's notes about revs including HLS. It's next to nothing $700,000. I'll post tomorrow
North, cdio saw that after hrs. Interesting yes they'll be at ACC amarin has a tiny booth in corner of conf hall. Maybe a rep from sarissa will be there?
622fast, Sarissa has been after ALKS for a couple of years if you go on linkedin for sarissa you'll find a few posts about the dance they've been doing on and off for a couple.
jroon, well now that's a moot point in light of the overwhelming win by Sarissa yesterday. I think AD has other ideas he wants to implement. Clearly, the script for today's call was written prior to yesterday's events.
Read my most recent post. KM should be fired just for his fraudulent statement re China amongst other BS he was flinging this morning. Why didn't someone ask when they expect to generate revenues from all the approvals received in 100's of countries around the world.... oh and in Puerto Rico as well.
KM is so full of BS read this excerpt from todays CC then read what's posted on the Eddingpharm pitchbook.
eventually, we'll have the total votes when amarin files the DEF14.
https://endpts.com/alex-denner-secures-victory-in-amarin-vote-ousting-chair-and-adding-supporters-to-board/
birdrock, I get the cardio metabolic shtick but diversified needs an explanation.
The New Amarin is on the right track toward transforming into a global, diversified cardiometabolic player as we execute a thoughtful and practical strategic plan designed to create value now. About Amarin Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management.
For anyone who listened to the CC did anyone pick up on KM's mentioning the introduction of additional applications for vascepa that will be introduced at the ACC Conf 3/4-6. Is it possible he was referencing Migtigate results?
birdrock, thank God Denner won the proxy contest after glancing through the financials I want to throw up.
They are working on the combo pill.
We are also advancing our fixed-dose combination (FDC) program for icosapent ethyl, which will improve the future value, penetration and long-term
value of our VASCEPA/VAZKEPA franchise in Europe. We see significant opportunities for our FDC portfolio to impact the product lifecycle in the
marketplace, while offering patients greater convenience and driving increased adherence.
They're knocking them dead in the other regions. LOL
Amarin recognized licensing and royalty revenue of approximately $0.7 million and $0.8 million during the three months ended December 31, 2022
and 2021, respectively, from VASCEPA-related commercial sales from our partners in Canada, the China region and the Middle East.
Birdrock, I was surprised that GSCO was even on the call since they have a sell rating on amrn.
Agreed the call was a non-event. One sentence about the changing of the guard.
jroon, I opened the link from Fidelity's newsfeed. I'll go to sec.gov and retrieve the pdf file.
http://archive.fast-edgar.com/20230301/AE2Z4222Z222C25S222N2W42J4ANZK22Z352
the 10K has the financial section cut off. I've never seen financials hidden in the back section of a report.
Has anyone noticed that problem?
Ranjov, wow where have u been?
Dogn, I eventually found it. Thx
Raf, if it was that obvious they should have met with sarissa to talk it out. How could they not know who they were up against? Their egos got in their way. Very dangerous. I'm curious to listen to tomorrow's conf call.
More money wasted paying the lobbyist too. Amarin are stupid small minded people.
has anyone noticed that when you search amarin's website it's almost impossible to find the content regarding the conf call tomorrow? I hate their new website. It's just plain old stupid. Awful design.
the canes, perfect, haven't heard that song in a while.
Hey Birdrock where are you??? Out celebrating??? Dare I say you were on this board to try to move the board members to #VOTE BLUE. Will we hear from you with your further words of wisdom?
tatsu, I believe you are forgetting that the results that will be announced tomorrow are for year end 2022. The form 4's were just issued a few days ago. So they will show up in the Q1 of 2023.
tatsu, That's fine with me I'm here to recoup my losses. I hope he does walk on water miracles do happen. Considering what has occurred in the past few years, at least with Denner we now have something to look forward to with his connections and experience. With all the horse shit the company has PR'd in the past few years nothing has come out of it except bleeding money every qtr building inventory, and receivables should I continue. Then at the 11th hour, they issue themselves a bunch of options cause they knew they were gonna lose. PWO nominates the last BOD when everyone was sleeping then issues an 8K 6 a.m. in the morning. He was stacking the board so Sarissa wouldn't be able to name the last 2 people on the board. Now it cost the shareholders over $7mill to lose to Sarissa which could have been avoided if they played ball with him rather than pick a fight with one of the most powerful biotech activists.
GIA in the EU was and is a disaster, I could go on but I'm not looking back only forward. Thank God Sarissa won.
Rosemount is on a cruise if anyone has a way of contacting him he should know about the Sarissa victory...
kiwi, yes indeed re Germany. He'll go back to the drawing board and make an offer they can't refuse. Maybe I'm putting too much stock (no pun intended) in his aptitude to achieve goals the average person wouldn't think of doing.
I've heard he's super intelligent.
DTG, yeah, I'm breathing a little easier now. Let me tell you that when I read the news I was over the top thrilled, out of body experience, etc. I'm thrilled that Denner's crew will be in the Board room. Also, looking forward to watching and learning how someone like Denner operates after a victory such as today. It's a powerful event that unfolded and shows we are stronger in numbers.
dar, I did too, a thank you note for their hard work and for giving hope to my retirement acct.
LOL
realcool, you're right keep in mind the in house attorney resigned recently and the CFO resigned less than a year after he came on board. Something is rotten in Switz.
I hope whatever their reasons were for booking the joint isn't too difficult to fix.
invest83838, yup, he's not doing this fight for his health. Denner knows the potential is there for vascepa to be a block buster molecule. It's all in marketing and branding.
I think Denner will build a demand the likes of which we could never have achieved with the trajectory the company is currently on. Double digit return is not out of the question.
robin, CHEERS!
james murphy, so how do you REALLY feel? LOL
invest83838, it's too soon to guestimate. He's got to wrap the package properly and then determine what the price discovery will be. We truly have no idea what the hidden values are because vascepa never had an opportunity to spread it's wings after the DUaster on 3/30/20.
So it's really had to say, I believe there will be another application for a rebranded vascepa but I have no idea what that may be.
nuke, the DEF14 proxy will contain the final counts. I'm elated that Sarissa won by such a huge margin. Now we know there won't be any pushback from the current remaining members of the board when a suggestion or recommendation is proposed. I would go so far as to say that many may step down. Maybe not the newbies but those who have served the longest. Some may even feel honored to learn from one of the best biotech activists on the street.
LBL, Diane Sullivan has an impressive cv. She would make a perfect COB. Although I think AD is equally as impressive he needs to take the reins and explore all avenues.
At this juncture, you are right, it doesn't matter.